BioCentury
ARTICLE | Financial News

Capella Bioscience completes venture financing

March 14, 2016 7:00 AM UTC

Capella Bioscience Ltd., London, U.K. Business: Cancer, Autoimmune Date completed: 2016-03-08 Type: Venture financing Raised: L11 million ($15.6 million) Investors: Advent Life Sciences; Medicxi Ventu...